Increase of adenosine doses in fractional flow reserve

Not Applicable

Completed

• Conditions: Coronary artery disease; Circulatory System; Atherosclerotic heart disease

• Registration Number: ISRCTN14618196
• Lead Sponsor: und University

Brief Summary

2017 results in https://pubmed.ncbi.nlm.nih.gov/28196527/ (added 27/11/2020)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2016-01-29
• Study Start: 2016-12-15
• Last Update Posted: 7 December 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 75

Inclusion Criteria

1. Age =18 years
2. Borderline-significant coronary stenosis (indication for FFR according to ESC Guidelines)
3. Signed informed consent prior to enrollment

Exclusion Criteria

1. Allergy to adenosine or contrast media
2. Baseline mean arterial pressure <60 mmHg
3. Baseline heart rate <50 bpm
4. Pharmacologically treated asthma
5. Chronic obstructive pulmonary disease equivalent to GOLD classification III and IV
6. Confusion or inability to comprehend the study information

Study & Design

• Study Type: Interventional
• Study Design: Not specified